0001615774-15-000552.txt : 20150324 0001615774-15-000552.hdr.sgml : 20150324 20150324161924 ACCESSION NUMBER: 0001615774-15-000552 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150320 FILED AS OF DATE: 20150324 DATE AS OF CHANGE: 20150324 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SECOND SIGHT MEDICAL PRODUCTS INC CENTRAL INDEX KEY: 0001266806 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 000000000 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12744 SAN FERNANDO ROAD, BLDG. 3 CITY: SYLMAR STATE: CA ZIP: 91342 BUSINESS PHONE: 818-833-5000 MAIL ADDRESS: STREET 1: 12744 SAN FERNANDO ROAD, BLDG. 3 CITY: SYLMAR STATE: CA ZIP: 91342 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Greenberg Robert J. CENTRAL INDEX KEY: 0001625594 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36747 FILM NUMBER: 15721963 MAIL ADDRESS: STREET 1: 12744 SAN FERNANDO ROAD, BLDG. 3 CITY: SYLMAR STATE: CA ZIP: 91342 4 1 s100905.xml FORM 4 X0306 4 2015-03-20 0 0001266806 SECOND SIGHT MEDICAL PRODUCTS INC EYES 0001625594 Greenberg Robert J. 12744 SAN FERNANDO ROAD, BLDG. 3 SYLMAR CA 91342 1 1 0 0 CHIEF EXECUTIVE OFFICER COMMON STOCK 2015-03-20 4 S 0 98742 13.28 D 224922 D COMMON STOCK 2015-03-23 4 S 0 1258 13.40 D 223664 D Option(b) 4.25 2017-01-01 Common Stock 125000 125000 D Option(c) 4.75 2015-09-01 Common Stock 150000 150000 D Option(d) 4.75 2016-01-01 Common Stock 17969 17969 D Option(e) 5.00 2016-05-01 Common Stock 8223 8223 D Option(f) 5.00 2017-01-01 Common Stock 30625 30625 D Option(g) 5.00 2018-02-01 Common Stock 23750 23750 D Option(h) 5.00 2018-11-01 Common Stock 150000 150000 D Option(i) 5.00 2019-02-01 Common Stock 23750 23750 D Option(j) 5.00 2020-02-01 Common Stock 53125 53125 D Option(k) 5.00 2020-02-01 Common Stock 50625 50625 D Option(l) 5.00 2021-03-01 Common Stock 41563 41563 D Option(m) 5.00 2022-03-01 Common Stock 29063 29063 D Option(n) 5.00 2024-04-01 Common Stock 11718 11718 D The price reported in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $13.01 to $13.95, inclusive. The reporting person undertakes to provide to the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. These transactions were effected pursuant to planned sales under lock-up agreement entered into at the time of EYES IPO in November 2014, as approved by Board of EYES and the IPO underwriter. The price reported in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $13.37 to $13.52 inclusive. The reporting person undertakes to provide to the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. These transactions were effected pursuant to planned sales under lock-up agreement entered into at the time of EYES IPO in November 2014, as approved by Board of EYES and the IPO underwriter. These are vested employee options currently exercisable. These options will vest and become exercisable within the next 60 days Excludes unvested employee options in amount of 459,503 shares, which are not exercisable for more than 60 days from this date. /s/ Robert J. Greenberg 2015-03-24